Calquence Tablet, Film Coated
Product Images NDC 0310-3512

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Calquence (NDC 0310-3512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

100mg_60_tablet_bottle (100mg 60 Tablets Bottle)

100mg_60_tablet_bottle (100mg 60 Tablets Bottle)
CALQUENCE® is a prescription medication available in the form of tablets with the NDC code 0310-3512-60. It contains acalabrutinib as the active ingredient. The medication is manufactured in Switzerland for AstraZeneca Pharmaceuticals LP based in Wilmington, DE 19850, and by AstraZeneca AB based in SE-151 85 Sodertalie, Sweden. The tablets are not to be chewed, crushed, dissolved, or cut.*
FDA Label Image

Chemical_structure (Chemical Structure)

Chemical_structure (Chemical Structure)
FDA Label Image

Figure_1 (Figure 1)

Figure_1 (Figure 1)
FDA Label Image

Figure_2 (Figure 2)

Figure_2 (Figure 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.